Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

Amycretin, a new weight loss drug developed by Novo Nordisk, helped participants lose up to 24.3% of body weight in just 36 ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...